Most Recent:

Title: It’s About the Brain, Not the Substance

The disease of addiction is a complex, progressive brain disease that is described in terms of specific substances but should be thought of as a brain disease, first and foremost. It is an individual’s interaction with the environment and environmental stimuli (including specific substances) that sets in motion the neurological changes that invariably lead to the disease of addiction. In this brief presentation, Dr. Galbis-Reig will use an analogy to describe and discuss these complex interactions so that attendees can better understand the disease of addiction as a primary brain disorder.

A recording of the presentation and a certificate of attendance will be available 24-48 hours after completion. You must be subscribed to our mailing list to receive a certificate.

Watch The Recording

Reducing Bias in Healthcare Starts with Destigmatizing Language

---

Detection of Benzodiazepines in Umbilical Cord Tissue

---

Misuse of Gabapentin

---

Identifying & Helping Newborns Affected by Alcohol & Other Drug Misuse

---

ChildGuard^® Testing: Environmental Exposure and Fentanyl Insights

---

Xylazine: An Adulterant Story

---

Choose the Best Test: An Overview of Advanced Alcohol & Other Drug Testing Options

---

Poster Overview: Prenatal Exposure to Kratom

---

Ethyl Glucuronide (EtG) in Hair & Nail: A Review and Recent Updates

---

Prevalence of Fentanyl and Coexposure in Newborns

---

Fetal Alcohol Spectrum Disorders: Components & Services Overview

---

Kratom: Should You Be Concerned?

---

Collection Site Panelist Discussion: Legal Professionals & Social Workers

---

Protecting Your Hospital with Forensic Newborn Drug Testing

---

The Detection of Buprenorphine in Hair

---

Newborn Toxicology: A Review and Recent Developments

---

The Detection of Fentanyl in Hair

---

Detecting Illicit Fentanyl in Newborns

---

Understanding Toxicology Reports: Confirmations, Cutoffs, and the Quantitative Values

---

Newborn Alcohol Biomarkers

---

Hair and Nail Testing: What’s the Difference?

---

Drug Trends and Concerns Regarding NAS

---

Environmental Exposure Drug Testing 101 (ChildGuard®)

---

Missed Opportunities in Newborn Drug Testing

---

Phosphatidylethanol Recent Developments

---

Protecting & Enriching Lives

---

FASD & Newborn Alcohol Biomarker Testing

---

Phosphatidylethanol (PEth) Overview

---

Meconium & Umbilical Cord Overview

---

Gabapentin Overview

---